The Risks and Rewards of Speed-to-IND Strategies With Susan Jones

September 12, 2023

What are some strategies that companies can use to get to IND filing quickly? In this brand new conversation, Evaluating Biopharma podcast host Ben Locwin discusses the risks and rewards of speed-to-IND strategies with Dr. Susan Jones, Chief Technology Officer at Tourmaline Bio. Dr. Jones delves into her 30 years of experience in the biotech industry, how quality by design impacts IND filing, and the pitfalls of using platform approaches to accelerate early development. Finally, she shares some case studies where accelerated timelines led to unexpected outcomes, as well as advice on knowing your situation and risks, and spending time understanding your molecule first.

GUEST BIO

Susan Jones, Chief Technology Officer, Tourmaline Bio
Susan Dana Jones, PhD, chief technology officer Tourmaline Bio, Inc., has more than 30 years of experience in the industry, including biopharmaceutical and vaccine product development, outsourcing, project management, quality and regulatory operations, and strategic planning. Dr. Jones previously served as SVP Product Development at Harpoon Therapeutics where she oversaw process development, technology transfer, and GMP production of multiple product candidates which are currently in clinical development. She previously was Vice President and Principal Consultant at BioProcess Technology Consultants (BPTC), where she focused on manufacturing requirements for advancement of product candidates from early discovery through all stages of clinical development. Prior to BPTC, Dr. Jones served as Senior Vice President of Corporate Development at Serenex, Vice President of Product Development at Waratah Pharmaceuticals, and Vice President Technology Strategy at Dyax Corp. Dr. Jones received her Bachelor's degree in biochemistry from Harvard University, holds a PhD in Genetics from the University of California, San Francisco, and performed post-doctoral research at the Dana-Farber Cancer Institute of Harvard Medical School.

MODERATOR BIO

Ben Locwin, Vice President of Project Solutions, Black Diamond Networks
Ben Locwin is a healthcare executive and industry expert. His work has involved bringing new and innovative medical treatments (drug therapies, vaccines and medical devices) to patient populations with unmet needs across a variety of indications and health conditions. He has also worked with investors on the ‘next big things’ in the industry. He has been featured in The Wall Street Journal, Forbes, USA Today, The Associated Press, Axios, NPR, and other top-tier media.